Five-Year Survival Rates for Treatment-Naive Patients With Advanced Melanoma Who Received Ipilimumab Plus Dacarbazine in a Phase III Trial

出版年份 2015 全文链接

标题

作者

关键词

出版物

Volume 33, Issue 10, Pages 1191-1196

出版商

American Society of Clinical Oncology (ASCO)

发表日期

2015-02-26

DOI

10.1200/jco.2014.56.6018

Discuss science. Find collaborators. Network.

Join a conversation

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now